| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8838859 | Brain Research Bulletin | 2018 | 17 Pages |
Abstract
Our results demonstrate that the use of GK-2 at the early stages of development of traumatic brain damage can prevent such delayed damage as neuronal and axonal degeneration as well as reduce TBI-related disruptions of brain functions.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Elisaveta E. Genrikhs, Dmitriy N. Voronkov, Marina R. Kapkaeva, Tatyana A. Gudasheva, Yuliya A. Glibka, Nickolay K. Isaev, Elena V. Stelmashook,